Compared with the single delivery of siAPE1 or melatonin, their co-delivery by 125I-loaded PSMA-R12 nanoparticles had superior efficiencies in inhibiting Bcl-2 expression and promoting apoptosis in PCa cells and suppressing PCa tumor growth in vivo. The gene discussed is BCL2; the disease is neoplasm.